As long as enrollment picks up, SSH will be $20s before Dec.
Don't miss the gravy train.
CF companies typically trade around $250M after feasibility results. That is $15 in terms of PPS.
If we want to use conservative projected sales, 5% global market capture with estimated odds for partnerships/royalties/successful results/approval/buyout, and at a 20% annual discount from peak sales in 10 years, we come to a FV of $20 before Dec '13, $30s a year later, and $80 before 2018.
With the financing overhang out of the way, this company is set to be an epic grinder for the next 2 years. Don't miss it.
old post... Patience Patience - and it requires more than a qtr or two or even three or four. SSH has enough cash right now for 4 or maybe 5 qtrs. focus on the C-Pulse then the C-Pulse II. if current mgmt can't accomplish forget the 'pill' it will be sold and certainly for more than 10 - 15.
A double in two-months seems very optimistic but I'll be happy to take it. The possibility is there if the TCT results are way over the top. Zero readmissions in one-month is sort of a Holy Grail and it already happened with the C-Pulse so I won't say it's impossible.